(Russian version) “Hilton Tashkent City” Hotel in Tashkent, Uzbekistan, hosted a scientific and practical conference “INTERDISCIPLINARY APPROACH TO THE TREATMENT OF RHINOSINUSITIS”. The Ministry of Health of the Republic of Uzbekistan, the Association of Doctors of the Republic of Uzbekistan in scientific partnership with the Representative Office of Pharmaceutical Company “Bionorica SE” (Germany) were organizers of this event. Specialized journal “Medical Express” was the information partner in this event. Vice-Rector for Academic Affars at Tashkent Institute for Postgraduate Medical Education (TIPME), Kasymova Munira Sadykjanovna and the Chairperson of ENT Department of the Association of Doctors of Uzbekistan, Professor of the Teaching Department for ENT Diseases at Tashkent Medical Academy, Dr. Med. Habil. Kh.E. Shaykhova, welcomed the conference participants. The focus of the conference was to highlight the benefits of Sinupret® Extract for treatment of acute uncomplicated inflammatory diseases of the paranasal sinuses (acute uncomplicated rhinosinusitis). Professor V. Popovich, Head of the Department of Otorhinolaryngology with the Course of Head and Neck Surgery, the Chairperson of the Expert Panel of the Ministry of Health of Ukraine delivered a presentation entitled “Sinupret® Extract. The Powerful Effects on Rhinosinusitis from the Evidence-Based Medicine Position”. In his presentation, the professor pointed out that the medicine produces a combined therapeutic effect on human body emphasizing that the key effect of the medication is the capacity to regulate production of mucus during rhinorrhea. He added that using the medicine from the onset of a common cold accompanied with rhinorrhea significantly expedites the recovery and prevents development of purulent complications (e.g., maxillary sinusitis, frontal sinusitis and others). Head of the Clinic and Professor of Ghent University, C. Bachert (Belgium), spoke next with a presentation “Sinupret® Extract: From Clinical Studies to Guidelines”. During his speech, he noted that Sinupret® Extract is an effective plant-based alternative to antibiotics for treatment of upper respiratory tract diseases. During the conference, a direct online broadcasting was set up for doctors from Samarkand, Bukhara, Andijan and Urgench cities in Uzbekistan.   “Medical Express” Press Correspondent. “Medical Express” Photo and Video Reporter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

“BIONORICA SE” Pharmaceutical Company’s CEO and  Chairman of the Executive Board, Professor Michael A. Popp, gave an exclusive interview to “Medical Express” Journal about effective treatment methods using innovative plant-based medicines presented at the Fifth Congress of Urologists in Uzbekistan and noted that Uzbekistan is a unique country with remarkable potential for scientific research. — Professor Popp, how does “BIONORICA SE” manage to effectively combine centuries-old knowledge with current achievements of scientific and technological progress? — “BIONORICA SE” uses the knowledge of history and empirical knowledge passed on by my grandfather to my father, who was also a physician specializing in research and production of plant-based medicines. At the same time, extensive experience of physicians including urologists underlies our developments. In combination, this enabled us to devise a completely new approach to using plant-based medicines. We think about how we can do the best state-of-the art modern science, we develop clinical protocols and conduct clinical studies with our products and we are very happy that at the end we succeed. We can show, for example, that our Canephron is as good as Fosfomicin in a patient with an uncomplicated urinary tract infection without the use of antibiotic in the first line. In almost 84% of monotherapy, our plant-based medicine was sufficient and female patients did not need an additional antibiotic leading to a high successful treatment rate, which was, in principle, impossible in the past. However, this success requires a lot of money and a lot of trust and belief in your product.    — The Fifth Convention of Urologists of Uzbekistan is taking place today. Developments regarding which medicine did “BIONORICA SE” present to the participants of this scientific forum? — One of key areas that we are exploring and presenting within our production are plant-based medicines. It is very important that you have the best raw materials. It means you have to take a lot of efforts to ensure constant homogenous quality of the product. It is important for each natural product to have the best quality of raw materials. Then, you need the best way of production, a modern way of production, to produce a good plant-based herbal medicine. Today, we presented Canephron that enabled us to show our newest developments. The newest developments show how Canephron works pharmacologically. It is important to point out that findings of clinical studies proved the effectiveness of this medication in treatment of uncomplicated urinary tract infections. We have currently proven that Canephron acts as good as Fosfomicin in cases of uncomplicated urinary tract infection. It is important because antimicrobial resistance of pathogens to various antibiotics, which eventually stop to work, is a problem that is so huge that even the World Health Organization focuses on it. — Dr. Popp, you've been coming for more than 10 years to Uzbekistan, could you, please, share your impressions? — About 10 лет years ago, I was fortunate to visit your country and back then I was astonished with the organization of the forum that took place in Tashkent and we were connect by video with doctors in Samarkand, Khiva and other cities and it worked. Today, I was pleasantly surprised to learn about two innovations – a questionnaire for acute cystitis developed in Uzbekistan and translated into 19 world languages and internationally validated, which we use in our scientific research. Secondly, a unique patient registration system was introduced in Uzbekistan and being introduced in several other countries. Today, I am convinced once again that Uzbekistan is a unique country with remarkable potential for scientific research.   “Medical Express” correspondent “Medical Express” photo and video reporter